Wed, Jan 28, 2015, 4:19 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Inovio Pharmaceuticals, Inc. Message Board

  • lieinhart lieinhart Sep 10, 2013 12:38 PM Flag


    At first I was disappointed with the low royalty. Then I remembered that Roche is paying Immunogen tiered yearly royalties of only 3 to 5 per cent (sales are tiered each year) for TDM-1, their blockbuster cancer drug. And INO should get better future royalty deals as their hand strengthens.

8.50-0.44(-4.92%)4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.